跳至主要内容
临床试验/IRCT2017092536415N1
IRCT2017092536415N1招募中未知

Evaluation of the efficacy of Ursodeoxycholic acid plus methotrexate compared with methotrexate alone on faster improvement of patients with plaque-type psoriasis

Tehran University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 70 years(—)
性别
All

入选标准

  • patients with psoriasis who are candidated for systemic therapy; they have not received systemic therapy as well as phtotherapy for their disease during the past 6 month; they have not received topical treatment over the past month.
  • Exclusion criteria: patients with history of heart failure, hepatic, renal and pulmonary disease or icreasement in liver function tests(More than 1.5 times normal), diabetes mellitus and other serious systemic disease; pregnant women; since the efficacy and safety of using Uroseodocyclic acid in the pediatric population has not been established, this group will also be excluded from the study; People with a history of biliary disorders, and hypersensitivity to bile acids

排除标准

  • 未提供

研究者

相似试验